» Articles » PMID: 36687047

Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations

Overview
Journal ACS Omega
Specialty Chemistry
Date 2023 Jan 23
PMID 36687047
Authors
Affiliations
Soon will be listed here.
Abstract

The CRISPR/Cas9 system is a popular genome-editing tool with immense therapeutic potential. It is a simple two-component system (Cas9 protein and RNA) that recognizes the DNA sequence on the basis of RNA:DNA complementarity, and the Cas9 protein catalyzes the double-stranded break in the DNA. In the past decade, near-atomic resolution structures at various stages of the CRISPR/Cas9 DNA editing pathway have been reported along with numerous experimental and computational studies. Such studies have boosted knowledge of the genome-editing mechanism. Despite such advancements, the application of CRISPR/Cas9 in therapeutics is still limited, primarily due to off-target effects. Several studies aim at engineering high-fidelity Cas9 to minimize the off-target effects. Molecular Dynamics (MD) simulations have been an excellent complement to the experimental studies for investigating the mechanism of CRISPR/Cas9 editing in terms of structure, thermodynamics, and kinetics. MD-based studies have uncovered several important molecular aspects of Cas9, such as nucleotide binding, catalytic mechanism, and off-target effects. In this Review, the contribution of MD simulation to understand the CRISPR/Cas9 mechanism has been discussed, preceded by an overview of the history, mechanism, and structural aspects of the CRISPR/Cas9 system. These studies are important for the rational design of highly specific Cas9 and will also be extremely promising for achieving more accurate genome editing in the future.

Citing Articles

Solid-State Nanopore Real-Time Assay for Monitoring Cas9 Endonuclease Reactivity.

Chau C, Weckman N, Thomson E, Actis P ACS Nano. 2025; 19(3):3839-3851.

PMID: 39814565 PMC: 11781028. DOI: 10.1021/acsnano.4c15173.


CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis.

Gu B, Li M, Li D, Huang K J Cardiovasc Transl Res. 2025; .

PMID: 39804565 DOI: 10.1007/s12265-024-10587-7.


Probing Electrostatic Interactions in DNA-Bound CRISPR/Cas9 Complexes by Molecular Dynamics Simulations.

Fatemi Abhari S, Di Felice R ACS Omega. 2024; 9(45):44974-44988.

PMID: 39554421 PMC: 11561601. DOI: 10.1021/acsomega.4c04359.


CRISPR/Cas technology: fueling the future of Biofuel production with sugarcane.

Ghane A, Malhotra P, Sanghera G, Verma S, Jamwal N, Kashyap L Funct Integr Genomics. 2024; 24(6):205.

PMID: 39495322 DOI: 10.1007/s10142-024-01487-9.


Current Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing Strategies.

Allemailem K, Almatroudi A, Alrumaihi F, Alradhi A, Theyab A, Algahtani M Int J Nanomedicine. 2024; 19:10185-10212.

PMID: 39399829 PMC: 11471075. DOI: 10.2147/IJN.S479068.


References
1.
Yin H, Song C, Dorkin J, Zhu L, Li Y, Wu Q . Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol. 2016; 34(3):328-33. PMC: 5423356. DOI: 10.1038/nbt.3471. View

2.
Jinek M, Jiang F, Taylor D, Sternberg S, Kaya E, Ma E . Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science. 2014; 343(6176):1247997. PMC: 4184034. DOI: 10.1126/science.1247997. View

3.
Slaymaker I, Gao L, Zetsche B, Scott D, Yan W, Zhang F . Rationally engineered Cas9 nucleases with improved specificity. Science. 2015; 351(6268):84-8. PMC: 4714946. DOI: 10.1126/science.aad5227. View

4.
Palermo G . Structure and Dynamics of the CRISPR-Cas9 Catalytic Complex. J Chem Inf Model. 2019; 59(5):2394-2406. DOI: 10.1021/acs.jcim.8b00988. View

5.
Palermo G, Ricci C, Fernando A, Basak R, Jinek M, Rivalta I . Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9. J Am Chem Soc. 2017; 139(45):16028-16031. PMC: 5905990. DOI: 10.1021/jacs.7b05313. View